Jung Hun Lee

Title: Jung Hun Lee: Innovator in Protein Kinase Inhibitors

Introduction

Jung Hun Lee is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target protein kinases. His work is crucial in the fight against diseases caused by abnormal cell growth, including cancer.

Latest Patents

Jung Hun Lee holds 2 patents that focus on thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors. The first patent describes a substituted thieno pyrimidine compound of Formula 1, which exhibits superior inhibition activity against various protein kinases involved in growth factor signal transduction. This compound and its compositions are useful for the prevention and treatment of diseases caused by abnormal cell growth, including cancer. The second patent discloses a 2,7-substituted thieno[3,2-d]pyrimidine compound that also demonstrates protein kinase inhibition activity. This compound serves as an effective ingredient in pharmaceutical compositions aimed at preventing and treating diseases related to abnormal cell growth.

Career Highlights

Jung Hun Lee is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His innovative work has positioned him as a key figure in the field of drug discovery and development.

Collaborations

Some of his notable coworkers include Tae Bo Sim and Hwan Geun Choi, who contribute to the collaborative efforts in advancing research in protein kinase inhibitors.

Conclusion

Jung Hun Lee's contributions to the field of medicinal chemistry, particularly through his patents on thieno[3,2-d]pyrimidine compounds, highlight his role as an innovator in the fight against cancer and other diseases caused by abnormal cell growth. His work continues to pave the way for new therapeutic strategies.